MGH American Cancer Society Institutional Research Grant
While the Mass General Cancer Center prides itself on presenting significant training opportunities for the approximately 75 junior investigators we have in any given year, the only source of funding for junior investigators’ pilot research projects is Massachusetts General Hospital's (MGH) Institutional Research Grant (IRG) from the American Cancer Society (ACS). This award supports MGH junior faculty to pursue cancer research. Cancer-related research is interpreted using the broadest definition, and includes, laboratory, clinical, prevention, health services, or population based projects.
Over the past eleven years, ACS IRG seed funding has allowed MGH junior investigators to collect pilot data that enables them to successfully compete for national competitive research grants from the NIH, NCI and others. Since 2012, the IRG has fostered innovate research and supported 53 junior faculty pilot studies at MGH. This work has already resulted in hundreds of peer-reviewed publications crediting ACS and dozens of externally funded grants for these researchers to continue their line of inquiry.
The IRG application process is administered internally through MGH every year. Future Calls for Proposals will be distributed by email and posted here on the Cancer Center website.
MGH American Cancer Society Institutional Research Grant Call for Pilot Project Proposals
The MGH Cancer Center is requesting applications for the MGH American Cancer Society Institutional Research Grant (ACS IRG) program. The purpose of ACS IRG program is to provide pilot funding for junior faculty pursuing cancer-related research. Cancer-related research is interpreted using the broadest definition, and includes laboratory, clinical, risk reduction, health services, or population-based projects. We anticipate funding up to 5 applications this year.
Application Deadline: 5:00 pm, Thursday, September 1, 2023
Applicant Guidelines:
To be eligible for an ACS IRG pilot grant the applicant must: be an MGH junior faculty member (faculty appointment as an Instructor or Assistant Professor as of September 2023).
- Applicants cannot have received prior, or hold current, major funding from a national peer-reviewed source (NIH, NSF, ACS, AHA, DOD, etc.). Career development award funding is acceptable (e.g. NIH K award).
- Candidates must be within 6 years of their initial post-training faculty appointment.
- Applicants must be citizens or noncitizen nationals of the United States or its possessions and territories, or must have been lawfully admitted to the United States for permanent residence at the time of application.
- Applicant’s department, disease center or research group leader must agree to commit $10,000 of departmental funds toward the award if funded.
- Applicants must have an identified mentor who agrees to provide a biosketch as part of the application
Project Guidelines:
- Priority will be given to applications which demonstrate promise to lead to further funding.
- Applications for novel clinical projects and for community-based projects are particularly encouraged in addition to basic science projects.
- Cancer-related research will be interpreted using the broadest definition.
- Special Interests awards are available for faculty members with an interest in the psychosocial, policy, prevention, cancer control, disparities and behavioral aspects of cancer and are strongly encouraged to apply.
- Project budgets are allocated up to $30,000 (direct costs) for one year. ACS IRG funds can be used to support project-related expenses only. Budgets must delineate if there is any other funding that would support/supplement the proposed research. Funds cannot be used for PI salary support.
Awardee Expectations:
- Local involvement with ACS in the form of events and lectures.
- Present at an MGH IRG Awardee conference.
- Provide annual updates on career progress.
If you are interested in submitting a proposal, please complete the project application (maximum 4 page research proposal (11 point font), not including references) and submit it along with an NIH biosketch and primary mentor’s NIH biosketch to Kerri Tortora (ktortora1@partners.org). If you have any questions, please email Elyse R Park, PhD, MPH (epark@mgh.harvard.edu).
All proposals will undergo an internal committee review.
ACS IRG Award Recipients
2023
Patrick Connor Johnson, MD
Instructor of Medicine
Development of a Multicomponent Supportive Care Mobile Application (THRIVE-CAR-T) for Patients Undergoing Chimeric Antigen Receptor T-cell Therapy (CAR-T)
Catherine Meador, MD, PhD
Instructor of Medicine
Applying Precision Oncology to SCLC Transformed EGFR-Mutant Lung Cancer
Peter Miller, MD, PhD
Assistant Professor of Medicine
The role of cigarette smoke in hematologic premalignancy and neoplasia
Uma Sachdeva, MD, PhD
Assistant Professor, Division of Thoracic Surgery MGH
Targeting Fibroblast Activation in the Development of Esophageal Adenocarcinoma
Jaime Schneider, MD, PhD
Assistant in Medicine Instructor Medicine, Division of Hematology/Oncology, MGH
Metabolic Reprogramming as a Driver of Resistance in Oncogene-Driven Lung Cancer
2022
Shadi Abdar Esfahani, MD, MPH
Targeting tumor microenvironment for treatment of gastric cancer
Jamie Jacobs, PhD
Assistant Professor, Harvard Medical School
A dyadic intervention for young adult patients with cancer and their partner caregivers
Julie Miller, MD, PhD
Instructor, Harvard Medical School
Targeting the CDK-Rb pathway in recurrent IDH-mutant glioma
Gary Wang, MD, PhD
Identifying and addressing access barriers contributing to screening mammography missed care opportunities at an MGH community health center-based screening center
2021
Adjoa Anyane-Yeboa, MD, MPH
Instructor in Medicine, Harvard Medical School
Improving Community Access to Colonoscopy for Colorectal Cancer Screening – A Pilot Program
Liron Bar-Peled, PhD
Assistant Professor of Medicine, Harvard Medical School
Chemical Proteomic Identification of Druggable Transcriptional Drivers in HR+ Breast Cancers
Tejaswini More Dhawale, MD
Instructor in Medicine, Harvard Medical School
Communication about Chimeric Antigen Receptor T-cell (CAR-T) Therapy: Patients’ and Caregivers’ Understanding of Their Treatment Risks and Benefits
Joseph Franses, MD, PhD
Instructor in Medicine, Harvard Medical School
Spatial transcriptional profiling of hepatocellular carcinoma tissue to define intratumor and intertumor heterogeneity
William L. Hwang, MD, PhD
Instructor of Radiation Oncology, Harvard Medical School
Cell state plasticity in pancreatic cancer tumorigenesis and therapeutic resistance elucidated by concurrent single-nucleus chromatin accessibility and gene expression
2020
Raj K. Gopal, MD, PhD
Instructor in Medicine, Harvard Medical School
Leveraging Genetic Insights to Detect and Target Hürthle cell carcinoma Vulnerabilities
Daniel L. Hall, PhD
Instructor / Assistant Professor of Psychiatry, Harvard Medical School
Adapted Telehealth Intervention for Insomnia among Cancer Survivors
Andrew S. Liss, PhD
Assistant Professor of Surgery, Harvard Medical School
Collagen XVII signaling in Pancreatic Cancer
Erica S. Shenoy, MD, PhD
Assistant Professor of Medicine, Harvard Medical School
Screening for Asymptomatic Clostridioides difficile Colonization Among Hematology/Oncology Patients at Time of Hospital Admission
Eric Wehrenberg-Klee, MD
Instructor of Radiology, Harvard Medical School
Evaluation of Adjunctive Cryoablation to Increase Pembrolizumab Response in Metastatic Urothelial Carcinoma
2019
Christine Chiasson-Mackenzie, PhD
Instructor in Medicine, Harvard Medical School
Macropinocytosis in human cancer
Zachariah DeFilipp, MD
Assistant Professor of Medicine, Harvard Medical School
Fecal microbiota transplantation capsules for steroid-refractory acute gastrointestinal graft-versus-host disease
Deborah A. Forst, MD
Instructor of Neurology, Harvard Medical School
Patient-Clinician Communication in Patients with Malignant Glioma
Rachel B. Jimenez, MD
Assistant Professor of Radiation Oncology, Harvard Medical School
Proton versus Conventional Radiation and Cardiac Structure and Function among Women with Breast Cancer
2018
Ibiayi Dagogo-Jack, MD
Instructor in Medicine, Harvard Medical School
Characterizing and Overcoming Alectinib Resistance in ALK + Lung Cancer
Anna Farago, MD, PhD
Instructor / Assistant Professor of Medicine, Harvard Medical School
Small cell lung cancer tissue microarrays for biomarker analysis
Efren Flores, MD
Instructor / Assistant Professor of Radiology, Harvard Medical School
Reducing Disparities in Lung Cancer Screening for Individuals with Severe Medical Illness
Laura Petrillo, MD
Instructor in Medicine, Harvard Medical School
Patient-Oncologist Communication and Decision Making Among Patients with Metastatic Non-Small Cell Lung Cancer and Targetable Mutations
Jacob Soumerai, MD
Clinical Instructor / Assistant Professor of Medicine, Harvard Medical School
Eradicating Minimal Residual Disease in Chronic Lymphocytic Leukemia
2017
Genevieve Boland, MD, PhD
Assistant Professor of Surgery, Harvard Medical School
Exosomal RNA as a tool for predicting and monitoring response to a PD1 therapy in melanoma
Lipika Goyal, MD, MPhil
Instructor / Assistant Professor of Medicine, Harvard Medical School
Identifying therapeutic strategies for FGFR inhibition in Intrahepatic Cholangiocarcinoma
Ryan Nipp, MD
Instructor / Assistant Professor of Medicine, Harvard Medical School
Identifying the components of informed treatment decision-making in patients with pancreatic cancer receiving preoperative therapy
Aparna Parikh, MD
Assistant Professor of Medicine, Harvard Medical School
Circulating tumor DNA to predict tumor recurrence in colorectal and pancreatic cancer patients undergoing resection with curative intent
Zofia Piotrowska, MD, MHS
Instructor / Assistant of Professor Medicine, Harvard Medical School
Overcoming heterogeneity and resistance in EGFR-mutant NSCLC
2016
Shadmehr Demehri MD, PhD
Assistant Professor / Associate Professor of Dermatology, Harvard Medical School
Mechanism of TSLP-induced Anti-tumor Immunity against Breast Cancer
Giselle Perez, PhD
Assistant Professor of Psychiatry, Harvard Medical School
Promoting Stress Management and Resilience Among Lymphoma Survivors Transitioning off Treatment
Mario Suva, MD, PhD
Assistant Professor / Associate Professor of Pathology, Harvard Medical School
Redefining human low-grade gliomas at single-cell resolution
Lara Traeger, PhD
Assistant Professor of Psychiatry, Harvard Medical School
Identifying critical elements of real-time discussions between providers, patients and families at the end of life
Shannon Stott, PhD
Assistant Professor of Medicine, Harvard Medical School
Engineering tools to elucidate the biogenesis and molecular content of exosomes
2015
Areej El-Jawahri, MD
Instructor / Assistant Professor of Medicine, Harvard Medical School
Psychological Distress, Symptom burden, Quality of Life, and Coping in Patients with Chronic Graft-Versus-Host Disease
Kelly E. Irwin, MD
Instructor / Assistant Professor of Psychiatry, Harvard Medical School
Early Psychiatry Consultation for Individuals with Severe Mental Illness and Cancer
David B. Sykes, MD, PhD
Instructor / Assistant Professor of Medicine, Harvard Medical School
Targeting the pathway of de novo uridine biosynthesis as differentiation therapy in the treatment of acute myeloid leukemia
Cesar M. Castro, MD, MSc
Instructor / Assistant Professor of Medicine, Harvard Medical School
Illuminating the Shadows of Cervical Disease using a Mobile Platform
Gabriela Hobbs, MD
Instructor / Assistant Professor of Medicine, Harvard Medical School
Pre-clinical Assessment of PD-1 as a Target in Myeloproliferative Neoplasms
2014
Amir Fathi, MD
Assistant Professor / Associate Professor of Medicine, Harvard Medical School
Assessing Minimal Residual Disease as a Predictor
Kasper Lage Hansen, MSc, PhD
Assistant Professor / Associate Professor of Medicine, Surgery, Harvard Medical School
Protein Network Rewiring Due to Somatic Driver
Inga Lennes, MD, MPH, MBA
Instructor in Medicine, Harvard Medical School
Personalized Patient Feedback Communication
Abner Louissaint, MD, PhD
Assistant Professor (Instructor at time of award) of Pathology, Harvard Medical School
Molecular Genetic Characterization of Pediatric-Type Follicular Lymphoma
Amity Manning, MD
Instructor in Medicine, Harvard Medical School
Manipulation of chromatin structure as a therapeutic approach to target CIN
2013
Catherine Lubitz, MD, MPH
Assistant Professor of Surgery, Harvard Medical School
Optimization of treatment of papillary thyroid cancer: a risk- tailored approach
Jorg Dietrich, MBA, MD, PhD, MMSc
Assistant Professor of Neurology, Harvard Medical School
Identification strategies to enhance endogenous nervous system repair following cancer therapy
Jennifer Wo, MD
Assistant Professor of Radiation Oncology, Harvard Medical School
Determination of prognostic significance of Bcl-2 and HPV 16, and mutational analysis following concurrent definitive chemoradiation for squamous cell carcinoma of the anal canal
Min Yu, MD, PhD
Assistant Professor (Instructor at time of award), Department of Stem Cell Biology and Regenerative Medicine; Norris Comprehensive Cancer Center of USC, University of Southern California
Characterizing the role of TAK1 in circulating tumor cells and metastasis
Jennifer Shin, MD
Instructor in Medicine, Harvard Medical School
Pilot study of a hospice video decision aid in patients with metastatic breast cancer
2012
Woo Jae Kim, PhD, MS
Instructor in Medicine, Harvard Medical School
Functional characterization of Wilms tumor suppressor WTX
Ryan Corcoran, MD, PhD
Assistant Professor of Medicine, Harvard Medical School
Identification of novel targeted therapy combination strategies for KRAS mutant cancers
Andrew Chi MD, PhD
Assistant Professor of Neurology, Harvard Medical School
Validating IDH1 mutation as a therapeutic target in glioblastoma
Travis Baggett, MD, MPH
Assistant Professor (Instructor at time of award) of Medicine, Harvard Medical School
Cancer incidence, prevalence, and mortality among homeless adults in Boston
Carlos G. Fernandez-Robles, MD
Instructor in Psychiatry, Harvard Medical School
Prevention of Delirium After Bone Marrow Transplantation
Education & Training at the Cancer Center
A world leader in cancer research & comprehensive cancer treatment, we are dedicated to educating the next generation of cancer specialists.
participated in Clinical Trials at the Mass General Cancer Center last year
This helped lead to new knowledge and breakthrough therapies.
Mass General Cancer Center
Contact the Mass General Cancer Center to make an appointment or learn more about our programs.